O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+5.11%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$9.48B
AUM Growth
+$9.48B
(+0.07%)
Cap. Flow
-$371M
Cap. Flow
% of AUM
-3.91%
Top 10 Holdings %
Top 10 Hldgs %
38.1%
Holding
152
New
12
Increased
38
Reduced
32
Closed
19
Top Buys
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$130M |
| 2 |
Merck
MRK
|
$98.2M |
| 3 |
Molina Healthcare
MOH
|
$91.7M |
| 4 |
Zimmer Biomet
ZBH
|
$91.4M |
| 5 |
MDVN
MEDIVATION, INC.
MDVN
|
$90.5M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$189M |
| 2 |
CELG
Celgene Corp
CELG
|
$135M |
| 3 |
HCA Healthcare
HCA
|
$126M |
| 4 |
AGN.PRA
Allergan plc.
AGN.PRA
|
$95.8M |
| 5 |
TSRO
TESARO, Inc.
TSRO
|
$84.2M |
Sector Composition
| 1 | Healthcare | 90% |
| 2 | Financials | 0.34% |
| 3 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Edwards Lifesciences
EW
$47.7B
| $51M | 0.53% |
1,534,200
+1,189,200
| +345% | +$39.5M |
|
|
LOXO
52
DELISTED
Loxo Oncology, Inc
LOXO
| $50.4M | 0.53% |
2,175,857
| – | – |
|
53
Cigna
CI
$80.2B
| $42.2M | 0.44% |
329,600
-5,900
| -2% | -$755K |
|
54
Insmed
INSM
$30.3B
| $41M | 0.43% |
4,158,600
+688,700
| +20% | +$6.79M |
|
55
SPDR S&P Biotech ETF
XBI
$5.29B
| $40.3M | 0.42% |
745,300
-235,900
| -24% | -$12.8M |
|
|
EGRX
56
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $40.2M | 0.42% |
+1,036,100
| New | +$40.2M |
|
|
ARRY
57
DELISTED
Array Biopharma Inc
ARRY
| $39.1M | 0.41% |
10,973,900
+284,900
| +3% | +$1.01M |
|
58
Dynavax Technologies
DVAX
$1.19B
| $35M | 0.37% |
2,403,300
+428,600
| +22% | +$6.25M |
|
|
ITCI
59
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $34.4M | 0.36% |
885,400
+591,400
| +201% | +$23M |
|
|
VRAY
60
DELISTED
ViewRay, Inc.
VRAY
| $32.7M | 0.34% |
7,989,916
| – | – |
|
|
DMTX
61
DELISTED
Dimension Therapeutics, Inc
DMTX
| $32.4M | 0.34% |
5,397,698
| – | – |
|
|
OTIC
62
DELISTED
Otonomy, Inc.
OTIC
| $29.4M | 0.31% |
1,850,094
| – | – |
|
63
Ascendis Pharma
ASND
$12.1B
| $29.1M | 0.3% |
2,191,000
+1,968,777
| +886% | +$26.1M |
|
64
Iovance Biotherapeutics
IOVA
$800M
| $27.4M | 0.29% |
3,382,900
+2,360,800
| +231% | +$19.1M |
|
65
Exact Sciences
EXAS
$9.33B
| $26.1M | 0.27% |
2,131,200
+240,800
| +13% | +$2.95M |
|
66
Cartesian Therapeutics
RNAC
$267M
| $25.8M | 0.27% |
+61,427
| New | +$25.8M |
|
67
Stryker
SYK
$149B
| $25.4M | 0.27% |
212,000
| – | – |
|
68
Tenet Healthcare
THC
$16.5B
| $25.3M | 0.26% |
+915,300
| New | +$25.3M |
|
|
SGYP
69
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $22.7M | 0.24% |
5,976,648
+3,700,000
| +163% | +$14.1M |
|
70
Galapagos
GLPG
$2.06B
| $19.6M | 0.2% |
352,700
+122,700
| +53% | +$6.81M |
|
|
IMGN
71
DELISTED
Immunogen Inc
IMGN
| $18.8M | 0.2% |
6,095,647
| – | – |
|
72
eHealth
EHTH
$126M
| $18.2M | 0.19% |
1,300,000
| – | – |
|
|
LUMO
73
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $17.8M | 0.19% |
175,723
+84,945
| +94% | +$8.61M |
|
|
CYNA
74
DELISTED
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
| $17.5M | 0.18% |
1,140,325
| – | – |
|
75
Xencor
XNCR
$594M
| $16.5M | 0.17% |
870,822
-236,200
| -21% | -$4.49M |
|